| 1398 |
1299: Activation, AKT |
1300: Activation, mTORC1 |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1400 |
1299: Activation, AKT |
1302: Activation, L-FABP |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1661 |
484: Activation, AKT2 |
457: Activation, SREBF1 |
Aug 31, 2017 |
Aug 31, 2017 |
1 AOP
|
| 1421 |
1309: Activation, aPKC |
1301: Activation, SREBP-1 |
Apr 13, 2017 |
Apr 13, 2017 |
None
|
| 3600 |
2354: Activation, Apoptosis signaling |
2355: Disrupted, Spermatogenesis and Sperm quality |
Aug 16, 2025 |
Aug 16, 2025 |
1 AOP
|
| 1079 |
1038: Activation, beta-2 adrenergic receptor |
1039: Increased activity, beta-2 adrenergic receptor |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3416 |
1038: Activation, beta-2 adrenergic receptor |
2284: Intracellular cAMP |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 1829 |
1575: Activation, Caspase 8 pathway |
55: Cell injury/death |
Jan 7, 2019 |
Mar 7, 2019 |
1 AOP
|
| 3051 |
2188: Caspase activation |
1825: Increase, Cell death |
Sep 14, 2023 |
Sep 14, 2023 |
1 AOP
|
| 77 |
66: Activation, ChREBP |
89: Synthesis, De Novo Fatty Acid (FA) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 483 |
66: Activation, ChREBP |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 711 |
715: Activation, Constitutive androstane receptor |
716: Increase, cell proliferation (hepatocytes) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1268 |
715: Activation, Constitutive androstane receptor |
1214: Altered expression of hepatic CAR-dependent genes |
Nov 29, 2016 |
Dec 21, 2018 |
1 AOP
|
| 379 |
398: Activation, Dendritic Cells |
272: Activation/Proliferation, T-cells |
Nov 29, 2016 |
Aug 22, 2022 |
2 AOPs
|
| 2987 |
2164: Activation, Dll4-Notch pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 20, 2023 |
Aug 20, 2023 |
2 AOPs
|
| 3011 |
2164: Activation, Dll4-Notch pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 962 |
941: Activation, EGFR |
914: Decreased ciliated cell apoptosis |
Nov 29, 2016 |
Aug 27, 2021 |
None
|
| 964 |
941: Activation, EGFR |
924: Activation, Sp1 |
Nov 29, 2016 |
Aug 11, 2021 |
None
|
| 965 |
941: Activation, EGFR |
919: Occurrence, Transdifferentiation of ciliated epithelial cells |
Nov 29, 2016 |
Aug 25, 2021 |
None
|
| 970 |
941: Activation, EGFR |
923: Increased goblet cell proliferation |
Nov 29, 2016 |
Aug 27, 2021 |
None
|
| 986 |
941: Activation, EGFR |
962: Increase, Mucin production |
Nov 29, 2016 |
Mar 9, 2023 |
1 AOP
|
| 2469 |
941: Activation, EGFR |
920: Goblet cell metaplasia |
Aug 25, 2021 |
Aug 27, 2021 |
None
|
| 2857 |
941: Activation, EGFR |
2117: Increase, goblet cell number |
Mar 15, 2023 |
Mar 16, 2023 |
1 AOP
|
| 936 |
913: Activation, Epidermal Growth Factor Receptor |
914: Decreased ciliated cell apoptosis |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 939 |
913: Activation, Epidermal Growth Factor Receptor |
923: Increased goblet cell proliferation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|